IRTC - Irhythm Holdings, Inc.

Insider Sale by Patterson Chad (CHIEF COMM, PRODUCT OFFICER)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

3 days ago, Patterson Chad, serving as CHIEF COMM, PRODUCT OFFICER at Irhythm Holdings, Inc. (IRTC), sold 4,444 shares at $128.44 per share, for a total transaction value of $570,804.00. Following this transaction, Patterson Chad now holds 58,164 shares of IRTC.

This sale represents a 7.00% decrease in Patterson Chad's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, March 2, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, March 3, 2026, 1 day after the trade was made.

Irhythm Holdings, Inc. operates in the HEALTHCARE sector, specifically within the MEDICAL DEVICES industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Patterson Chad

CHIEF COMM, PRODUCT OFFICER

Chad Patterson is Chief Commercial & Product Officer at iRhythm Technologies, Inc. (IRTC), a position he has held since June 2025, following his role as Chief Commercial Officer starting in July 2022.[[1]](https://investors.irhythmtech.com/news/news-details/2022/iRhythm-Technologies-Announces-Chief-Commercial-Officer-Transition-and-Schedules-Second-Quarter-Earnings-Release-and-Conference-Call-for-August-4-2022/default.aspx)[[2]](https://fintool.com/app/research/companies/IRTC/people/chad-patterson)[[4]](https://investors.irhythmtech.com/governance/board-of-directors/person-details/default.aspx?ItemId=43ded273-606e-4425-b5a7-7350c704040b) He joined iRhythm after serving as Executive Vice President and Chief Marketing Officer at Dexcom, Inc. from January 2021 to July 2022, where he oversaw global product management, design, clinical education, customer experience, research, public relations, and marketing, contributing to revenue growth from $400 million to a forecasted $2.9 billion in 2022 and expansion into over 50 countries.[[1]](https://investors.irhythmtech.com/news/news-details/2022/iRhythm-Technologies-Announces-Chief-Commercial-Officer-Transition-and-Schedules-Second-Quarter-Earnings-Release-and-Conference-Call-for-August-4-2022/default.aspx)[[2]](https://fintool.com/app/research/companies/IRTC/people/chad-patterson)[[4]](https://investors.irhythmtech.com/governance/board-of-directors/person-details/default.aspx?ItemId=43ded273-606e-4425-b5a7-7350c704040b) Earlier, Patterson held progressive roles at Dexcom from 2015 to 2021 and global strategic brand and product management positions at Nestlé from 2005 to 2015, including developing the 10-year strategy for Nestlé's Coffee-Mate® brand.[[1]](https://investors.irhythmtech.com/news/news-details/2022/iRhythm-Technologies-Announces-Chief-Commercial-Officer-Transition-and-Schedules-Second-Quarter-Earnings-Release-and-Conference-Call-for-August-4-2022/default.aspx)[[2]](https://fintool.com/app/research/companies/IRTC/people/chad-patterson)[[4]](https://investors.irhythmtech.com/governance/board-of-directors/person-details/default.aspx?ItemId=43ded273-606e-4425-b5a7-7350c704040b) Patterson earned a Bachelor of Arts in Marketing, Entrepreneurship, and International Business from Gonzaga University, where he played Division I soccer, and a Master of Business Administration from the University of Southern California Marshall School of Business.[[1]](https://investors.irhythmtech.com/news/news-details/2022/iRhythm-Technologies-Announces-Chief-Commercial-Officer-Transition-and-Schedules-Second-Quarter-Earnings-Release-and-Conference-Call-for-August-4-2022/default.aspx)[[2]](https://fintool.com/app/research/companies/IRTC/people/chad-patterson)[[4]](https://investors.irhythmtech.com/governance/board-of-directors/person-details/default.aspx?ItemId=43ded273-606e-4425-b5a7-7350c704040b) Under his leadership at iRhythm, the company achieved 20.1% year-over-year revenue growth, record new account openings, deeper penetration in IDN/national accounts, and expansions into European markets and Japan launch readiness.[[2]](https://fintool.com/app/research/companies/IRTC/people/chad-patterson) As a corporate insider, he recently sold 8,967 shares on February 25, 2026, for approximately $1.2 million, retaining 51,738 shares.[[6]](https://www.investing.com/news/insider-trading-news/irhythm-holdings-chief-comm--product-officer-sells-12m-in-shares-93CH-4530386)

View full insider profile →

Trade Price

$128.44

Quantity

4,444

Total Value

$570,804.00

Shares Owned

58,164

Trade Date

Monday, March 2, 2026

3 days ago

SEC Filing Date

Tuesday, March 3, 2026

Filed 1 day after trade

HEALTHCAREMEDICAL DEVICES

About Irhythm Holdings, Inc.

Company Overview

No company information available
View news mentioning IRTC

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/4470953

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime